Loeb Partners Corp’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
Loeb Partners Corp's NVO Position: Q3 2018 in Review
Loeb Partners Corp sold out of Novo Nordisk (NVO) in Q3 2018, closing a stake of 40,000 shares.
Loeb Partners Corp first reported a position in NVO in Q3 2013 and held it in 6 quarters. The position peaked at $1.07M in Q4 2017. 558 funds tracked by Wall St. Rank hold NVO as of Q3 2018.
- Loeb Partners Corp reported no remaining Novo Nordisk position as of Q3 2018 after selling out during the quarter.
- Loeb Partners Corp sold 40,000 Novo Nordisk shares in Q3 2018.
- Loeb Partners Corp first reported a position in Novo Nordisk in Q3 2013 and held it in 6 quarters.
- Loeb Partners Corp's Novo Nordisk position peaked at $1.07M in Q4 2017.
- 558 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.
Based on Loeb Partners Corp's 13F filing for Q3 2018, filed 9 Nov 2018.